Tue, Mar 3, 2015, 8:25 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Allergan Inc. Message Board

  • saurai saurai Jan 22, 2013 10:48 PM Flag

    MAPP aquistion is looking like a solid move. PATH is a simliar opp that is quite promising.

    I am expecting a nice move in PATH in tandem with MAPP. Take a look and see the details before the exptected runup. Again, Great move AGN!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Why didn't they make a run at ALEXA-Alreadly have FDA approval for the Staccato delivery system?

      Maybe they will still make a run at ALEXA-Would be a very inexpensive acquesition.

      Sentiment: Hold

    • I love AGN's ultra low beta. It discourages the chart guys and program traders from trying to push prices around. This is a solid growth company whose value has not been clouded by the momentum traders. I am a buyer on this pullback.

      Sentiment: Buy

    • I agree that this is a great move.
      There is so much opportunity for effective treatments in the migraine space and AGN could become a major player with Botox and MAP Pharm.'s Levadex.
      This is a solid strategic move that will pay off -- BIG time -- for AGN.
      This should make AGN an even more attractive, plus exiting stock, when you add the recent acquisition of SkinMedica, coupled with last Friday's approval of Botox for over-active bladder -- OAB.
      Management is positioning this company to lead, grow and shine for years to come.
      What a bonanza!!

234.86-0.94(-0.40%)Mar 3 4:01 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.